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Abstract— Lung cancer is the leading cause of cancer death 
and morbidity worldwide with early detection being the key to 
a positive patient prognosis. Although a multitude of studies 
have demonstrated that machine learning, and particularly 
deep learning, techniques are effective at automatically 
diagnosing lung cancer, these techniques have yet to be clinically 
approved and accepted/adopted by the medical community. 
Most research in this field is focused on the narrow task of 
nodule detection to provide an artificial radiological ‘second 
reading’.  We instead focus on extracting, from chest X-ray 
images, a wider range of pathologies associated with lung cancer 
using a computer vision model trained on a large dataset.  We 
then find the set of best fit decision trees against an independent, 
smaller dataset for which lung cancer malignancy metadata is 
provided.  For this small inferencing dataset, our best model 
achieves sensitivity and specificity of 85% and 75% respectively 
with a positive predictive value of 85% which is comparable to 
the performance of human radiologists. Furthermore, the 
decision trees created by this method may be considered as a 
starting point for refinement by medical experts into clinically 
usable multi-variate lung cancer scoring and diagnostic models. 
Keywords—Artificial Intelligence, Machine Learning, 
Computer Vision, Lung Cancer, Malignancy Model, Explainable 
AI, Automatic Model Generation   
I. INTRODUCTION 
Lung cancer is the leading cause of cancer death 
worldwide [1] with over 2 million new cases in 2018 and 
rising. There is a long history of research into automated 
diagnosis of lung cancer from medical images using computer 
vision techniques encompassing linear and non-linear filtering 
[2], grey-level thresholding analysis [3], and, more recently, 
machine learning including deep learning techniques [4-7]. 
However, despite the many lab-based successes of computer 
vision medical image diagnostic algorithms, the actual 
approval and clinical adoption of these computer vision 
techniques in medical image analysis is very limited. As of 
September 2020 the U.S. Food and Drug Administration 
(FDA) has approved only 30 radiology related deep learning 
or machine learning based applications/devices of which only 
three utilize the X-ray imaging mode [8] with the subject of 
one being wrist fracture diagnosis (FDA DEN180005) and the 
other two being for pneumothorax assessment (FDA K190362 
and K183182). 
In contrast to the limited number of field applications 
relating to clinical use of machine learning, there exists a 
massive corpus of published research in this field. The Scopus 
database [9] returns over 700 results from 1988 to the present 
for a title and abstract search on ("Computer Vision" OR 
"Machine Learning" OR "Deep Learning" AND chest AND 
X-ray). The overwhelming majority of these papers have been 
authored in the past decade as shown in Figure 1. There is, 
however, a significant gap between this massive research and 
development effort and the lack of approved clinical 
applications for the automated diagnosis of lung cancer from 
CXR. 
 
Fig. 1. Scopus bibliographic histogram relating to Machine Learning Chest 
X-Ray. 
Driving this huge interest in medical computer vision 
research is a desire to provide tools to improve the 
productivity of medical clinicians. In the case of radiology, the 
objective of most research efforts in the field of automated 
medical imaging interpretation is to provide an automated 
“second reading” to assist radiologists with their workloads. 
This ambitious goal has arguably been met under lab 
conditions over the course of many studies [10]. However, the 
lack of any clinically approved multi-class Chest X-ray (CXR) 
based computer vision diagnostic tool evidences the difficulty 
of translating success in the lab to engineering that is useful 
outside lab-controlled conditions. 
This paper takes a different approach to the application of 
machine learning to automated lung cancer diagnosis and 
stratification. Rather than aiming to provide an automated 
second reading, our objective is to autonomously create a 
range of reasonable, explainable decision tree models for lung 
cancer malignancy scoring.  Our intention is that that these 
models can be used by the medical community as a data driven 
foundation for multivariate diagnostic scoring of lung cancer. 
We extend the typical method of training a deep learning 
algorithm (usually a variant of the Convolutional Neural 
Network architecture) in lung nodule detection and 
classification into a two-step approach that combines deep 
learning multiple-feature extraction with automatic fitting of 
decision trees. 
Firstly, we investigate lung pathology features that are 
closely associated with lung cancer then use these conditions 
to train a multi-class deep learning algorithm. Secondly, the 
score for each condition (score tuple) is inferenced from the 
trained model against an independent lung cancer CXR 
dataset for which malignancy scoring metadata is available. 
Finally, the score tuple is fitted to the malignancy data for each 
patient using a simple decision tree with the most accurate 
decision tree/s extracted as a base for future clinical/empirical 
study by the medical community. 
This more holistic approach, which emphasises the 
importance of multiple features along with interpretability and 
human judgement in the creation of medical computer vision 
applications, may help overcome the hurdles that have held 
back the acceptance and widespread use of medical artificial 
intelligence algorithms in the field. 
II. RELATED WORK 
A. Recent Work on Automated Lung Cancer Diagnosis 
Although the Computed Tomography (CT) imaging mode 
has attracted most of the machine learning lung cancer 
diagnostic research, there are a number of studies that show 
the usefulness of CXR for this task. Best results against the 
very large Chest-Xray14 dataset [11] was achieved using a 
hybrid approach of deep learning combined with local feature 
extraction achieving an average AUC of 0.8097 for thirteen 
conditions (the “No Finding” class being excluded) [12] 
representing a significant improvement over the results of the 
Chest-Xray14 authors. Other recently successful approaches 
include incorporation of label dependencies via LSTM 
modules [13] and consideration of the relationship between 
pathology and location in the lung geometry [14]. Good 
results in lung nodule detection using deep learning have been 
achieved by teams using other datasets with a systematic 
survey for this research up to 2018 being provided by [15] 
These studies tend to focus on lung nodules only, which is 
problematic for two reasons; firstly, a lung nodule is defined 
as measuring ≤ 3 cm in diameter [16] with larger nodules or 
masses typically ignored in these studies even though these 
may indicate more serious and likely malignant cancers, and 
secondly, most pulmonary nodules are benign [17]. These two 
factors combined would logically lead to existing deep 
learning systems tending to over diagnose benign conditions 
as lung cancer (where the study equates lung cancer to the 
presence of detected nodules) and under diagnose serious 
nodules and masses over 3 cm in diameter. Both consequences 
are obviously highly undesirable. 
B. Recent Work on Automated Diagnostic Scoring from 
Medical Images 
Interest in severity scoring from CXR images has received 
some recent focus due to the COVID-19 pandemic of 2020.  
A combination of deep learning feature extraction and logistic 
regression fit to severity has been shown to be predictive of 
the likelihood of ICU admission for COVID-19 patients [18].  
A large number of papers on classification of lung nodules 
detected from the CT imaging mode have been published 
employing various deep learning techniques [19], however 
few such papers have been published for the CXR imaging 
mode.  This is most likely due to the CXR imaging mode 
having lower sensitivity in comparison to the CT imaging 
mode [20], making nodule characterisation difficult using 
traditional segmentation and shape analysis techniques. 
III. DATA SETS 
A. Data Sourcing 
In order to achieve our objectives two datasets are needed.  
The first is a large corpus of labelled CXR data that can be used 
to train a deep learning classifier as a feature extraction 
component.  The National Institute of Health (NIH) ChestX-
ray14 dataset [21] provides over 100,000 such images being 
uniformly 1024 x 1024 pixels in a portrait orientation with both 
Posterior-Anterior (PA) and AP views.  The second necessary 
dataset must comprise CXRs with malignancy metadata 
indicating whether lung cancer is present in the image and if 
so, whether the cancer is considered by expert radioloists to be 
benign or malignant.  The Lung Image Database Consortium 
Image Collection (LIDC-IDRI) [22] CXR subset meets these 
requirements and additionally provides metadata desribing 
whether a malignant cancer originates in the lung or elsewhere.  
The LIDC-IDRI dataset has been manually labelled by four 
radiologists with access to corresponding patient CT scans.  
The label metadata has been provided at the patient level, 
meaning that there are some images provided where the nodule 
location is known and logged from the CT scan but not visible 
on the CXR image. 
  Normally, any such inconsistency between the dataset and 
it’s labels would be problematic for a computer vision 
diagnosis since the image data would not support the binary 
label ground truth. Our more holistic classification should be 
relatively robust to this problem since the presence of visible 
nodules is only one of a number of features under 
consideration.   
Although we could find no indication of the projection used 
for the LIDC-IDRI images, they appear to be posterior-anterior 
as indicated by ribs clearly being in front of the spinal column 
along with the unclear scapula which is obfuscated by the lung 
field. 
B. Data Curation 
The NIH data set contains 112,120 CXR images from 
30,805 unique patients with a mix of both posteroanterior 
(PA) and anteroposterior (AP) projections.  The dataset has 
been labelled using natural language processing to extract 
disease classes for each image from the associated radiology 
report, which the NIH dataset authors claim are of greater than 
90% accuracy.  Many of the images have a mix of disease 
classes.  Since our objective is to achieve explainable lung 
cancer scores, we have restricted this study to images labelled 
with only a single disease class. 
Not all of the disease classes included in the NIH data set 
are indicative of lung cancer.  In order to either exclude or 
include the classes the simple rule was applied.  If the 
literature noted a general indicative connection between lung 
cancer and the class in question then that class was to be 
extracted from the NIH set for further analysis.  The only 
exception to this inclusion rule is the “No Finding” class was 
included to enrich the generated models with a contra 
indicator.  This resulted in five classes of interest for this study 
being Atelectasis, Effusion, Mass, No Finding, and Nodule.  
Once filtered in this way the totals for images in this dataset 
are as included in Table I. 
TABLE I.  COUNT OF NIH IMAGES FOR SINGLE CLASSES 
NIH Image Data (Single Class) Summary 
Classification Count Extracted Associated with Lung Cancer 
Atelectasis 2210 Y 
Has been documented as a first 
sign of lung cancer [23]. 
Cardiomegaly 746 N 
Not related to lung cancer 
although in rare cases 
misdiagnosed when underlying 
condition is mass in same 
geography of CXR [24]. 
Consolidation 346 N 
Can sometimes accompany 
lung cancer but usually 
associated with pneumonia 
[25]. 
Edema 51 N 
Can be a complication from 
treatment for lung cancer but 
does not indicate lung cancer 
[26]. 
Effusion 2086 Y 
Can be caused by a build up of 
cancer cells and a common 
complication of lung cancer 
[27]. 
Emphysema 525 N 
Has been linked as a risk factor 
for lung cancer but not an 
indication [28]. 
Fibrosis 648 N 
Has been linked as a risk factor 
for lung cancer but not an 
indication [29]. 
Hernia 98 N 
Has been mistaken for lung 
cancer but does not indicte lung 
cancer [30]. 
Infiltration 5270 N 
Generic descriptor used 
informally in radiological 
reports and not actually an 
accepted lung disease 
classification. 
Mass 1367 Y 
A primary indication of lung 
cancer [26]. 
No Finding 39302 Y 
By definition not lung cancer 
but included to enrich 
generated models with a 
counter-indicator. 
Nodule 1924 Y 
A primary indication of lung 
cancer [26, 31] with about 40% 




This is often an indication of 
mesothelioma caused by 
exposure to asbestos.  It is also 
NIH Image Data (Single Class) Summary 
Classification Count Extracted Associated with Lung Cancer 
a very common abnormal 
finding on CXR.  It is not an 
indication of lung cancer [32]. 
Pneumonia 176 N 
Often a compication of lung 
cancer [25] with 50-70% of 
patients developing a lung 
infection.  Persistent 
pneumonia can lead to a 
diagnosis of lung cancer.  Not 
typically used as indicator of 
lung cancer. 
Pneumothorax 1506 N 
Can be the first sign of lung 
cancer but this is rare [33]. 
 
To address class imbalance during training, the classes 
were under-sampled to 2000 examples of each class.  This left 
the “Mass” and “Nodule” labels as minority classes with 1367 
and 1924 samples respectively.  This remaining imbalance 
was addressed in training by means of a weighted random 
sampler in the data loader.   
Standard augmentations were applied only to the training 
NIH dataset with random rotation of 1 degree with expansion, 
and random horizontal flip.  Vertical flipping was not used 
since CXR images are not vertically symmetrical. Training 
and testing were run with and without equalization.  The 
images were then resized with a default size of 244 x 244 
pixels. 
The NIH dataset was split into an 80:20 training and 
validation pair resulting in 6641 images for training and 1661 
images for validation.  A set of 6085 images (conforming to 
the NIH recommended test set) was used as a holdout test set.  
Since these images were drawn from the recommended NIH 
test split there was no patient overlap between the data used 
for training and testing. 
No curation or processing other than resizing and 
equalization matching the training set was applied to the 
LIDC-IDR dataset. 
IV. MODEL DEVELOPMENT 
A. Network Selection 
Following experimentation with a number of classifiers 
including VGG-19 [34], AlexNet [35] , DenseNet-121 [36], 
ResNet-50 [37] and ResNext-50 [38], we found that 
DenseNet-121 network initialized with ImageNet [39] 
weights consistently gave the best results. In contrast to the 
ResNet variants, DenseNet did not seemingly benefit from 
staged training [40] thereby allowing for a simpler 
experimental setup. We therefore selected the DenseNet121 
architecture for the study which is consistent with other 
studies relating to the use of deep learning classifiers on large 
CXR datasets [41-43]. 
We followed standard practice employed in transfer 
learning [44] and replaced the output fully connected layer (by 
default 1000 neurons) with the number of classification 
outputs required by the experiment being five. These five 
output nodes matched our five selected features being 
Atelectasis, Effusion, Mass, No Finding, and Nodule. After 
experimenting with trainable output head layers vs simply 
fine-tuning the entire model we found that the entire model 
fine-tuning approach worked best for DenseNet121 with 
AUC-ROC results comparable to state-of-the-art for this 
dataset in consideration that we have restricted classes and 
under-sampled (Table III).  
The Adam optimizer [45] was used along with a cosine 
annealing learning rate scheduler with learning rate of 0.001. 
This scheduler was selected because during model testing and 
hyperparameter optimization, it was noticed that the model 
trained well with a more aggressive learning rate, leading to 
higher validation accuracy at a lower number of epochs. 
Finally, we chose to test with both the standard binary 
cross entropy and focal loss [46] functions since inspection of 
the NIH dataset revealed that many images were objectively 
low quality (due to overexposure, improper patient position, 
presence of intrusive medical devices and differing focal 
distance) resulting in a number of sample images that could be 
considered to be adversarial to training. We hypothesised that 
a focal loss function might allow the model to better account 
for the adversarial images thereby allowing good results 
without curating these images out of the dataset manually at 
the risk of introducing sampling bias.  The tests performed are 
summarised in table II below. 
TABLE II.  TEST IDENTIFICATION AND SUMMARY 
Test ID Loss Function 
Histogram 
Equalization 
A BCE TRUE 
B BCE FALSE 
C FOCAL TRUE 
D FOCAL FALSE 
 
The results of 10 training/holdout testing runs are shown 
in Figures 2 – 5 below. 
 
Fig. 2. Average AUC-ROC for 10 Round of Holdout Testing (Test A) 
 
Fig. 3. Average AUC-ROC for 10 Round of Holdout Testing (Test B) 
 
Fig. 4. Average AUC-ROC for 10 Round of Holdout Testing (Test C) 
 
Fig. 5. Average AUC-ROC for 10 Round of Holdout Testing (Test D) 
B. Model Selection 
Inspection of the average AUC-ROC curves for the tested 
combinations of equalization and loss functions (figures 2-5 
above) led us to hypothesise that the equalized BCE model 
corresponding to test A would be preferred for LIDC dataset 
inferencing and decision tree generation. This configuration, 
as shown in figure 2, was the most consistent performer with 
the majority of average AUC-ROC scores between 0.75 and 
0.8 with only a single outlier returning an average AUC-ROC 
value below 0.73.  Best AUC-ROC values for the extracted 
features for each tested configuration are shown in table III 
below with highest score for each feature in bold. Also 
included as a baseline are the AUC-ROC values for the same 
conditions from the original NIH paper [11] from their best 
reported classifier (ResNet50) and the most relevant state-of-
the-art results from [47], noting that these papers also 
considered additional conditions in their multi-classifier and 
did not restrict the CXR images to PA projections meaning 
that results are not directly comparable.  
We interpret our slightly improved scores compared to 
[11] and [47] as a result of filtering the dataset for our purposes 
as described above, thereby reducing the label noise in the 
dataset which has been estimated by some commentators as 
up to 10% [48]. We do note that other teams have achieved 
even better results than [47] by applying additional data sets 
[14] and hand-crafted shallow feature integration [12], 
however at best these results are on average only 1.4% 
improved upon ours. Our approach is that pure deep learning 
is enough to meet the objectives of this study with the 
significant benefits of simplicity, efficiency and adaptability 
to a federated model in the future. 
From the model training AUC-ROC curves we 
hypothesised that the most accurate models for the inference 
stage of the experiment would be in the range of 9-11 epochs, 
corresponding to the peaks of the holdout testing polynomial 
fit curve. 
TABLE III.  AUC-ROC SCORES FOR NIH SUBSET  
NIH Image Data (Single Class) Summary 
Configuration Atelectasis Effusion Mass Nodule 
Test A 
(Epoch 8) 
0.779 0.843 0.821 0.725 
Test B 
(Epoch 8) 
0.767 0.858 0.795 0.714 
Test C 
(Epoch 9) 
0.754 0.849 0.817 0.739 
Test D 
(Epoch 10) 
0.753 0.869 0.810 0.733 
Wang et 
al.[11] 
0.700 0.759 0.693 0.669 
Yao et al.[47]  0.733 0.806 0.778 0.272 
V. MALIGNANCY MODEL GENERATION 
A. Method 
157 CXR images from the LIDC dataset that included 
patient level diagnosis metadata were extracted from DICOM 
format into PNG format to match the classifier training data 
format.  Of these, images 27 were classified with a diagnosis 
of “Unknown” and were excluded from further analysis.  The 
remaining 130 records were categorised by the LIDC as 
follows: 
TABLE IV.  LIDC PATIENT LEVEL DIAGNOSIS METADATA SUMMARY 
LIDC Image Diagnosis Summary 
Diagnosis Description Number of Images 
1 
benign or non-malignant 
disease 
36 
2 malignant, primary lung cancer 43 
3 malignant metastatic 51 
 
The DenseNet121 models were used to extract 
pathological feature scores for the LIDC images.  Inferencing 
was performed from saved models of all training epochs and 
runs resulting in 150 models for each combination of 
equalization and loss function.  A seven-column csv template 
was prepared containing columns for the Patient ID, 
placeholders for the five features of interest (including the “No 
Finding” class), and the diagnosis score 1 to 3 as determined 
by four experienced thoracic radiologists [49].  Diagnosis 
scores 2 and 3 were combined into a single malignancy class 
with 94 images. representing malignant diagnosis and thereby 
allowing for a binary separation.   Values for “Atelectasis”, 
“Effusion”, “Mass”, “No Finding” and “Nodule” were 
inferenced from the Densenet121 models as a score tuple and 
written to the placeholder columns to complete a data-frame 
of patients, inferenced feature scores and diagnosis label.  The 
inference reference files are available as supplementary 
information. 
The data-frame was then randomly split into an 80:20 
Training/Testing set (resulting in 26 records reserved for 
holdout testing) before being used to fit a decision tree 
classifier with a limited maximum depth of 3 (in order to 
reduce overfitting due to the small sample size) fitting on an 
entropy criteria.  The fit accuracy was captured and written to 
a CSV file, and the tree view generated was captured as an 
image file for any model with greater than 60% accuracy for 
further investigation of the associated confusion matrix and 
tree as a potentially useful diagnostic model. This process is 
summarised in Figure 6. 
An experiment was scripted for all combinations of 
training epoch/round, loss function (BCE and Focal) and 
histogram equalization usage. 
 
Fig. 6. Automatic Model Generation Process. 
VI. RESULTS 
The majority of fitted decision trees achieved accuracy of 
60% or greater with the combination of focal loss without 
equalization proving to be the most consistent with 92% of 
trees meeting this criterion.  The most accurate decision tree 
generated using the method described achieved 85% accuracy 
with positive predictive value of 83% for test C using a 
combination of focal loss function and histogram equalization. 
All tests achieved best accuracy greater than 81%, with 
sensitivity in the range 85-100%  and specificity in the range 
29-75% which (accounting for sensitivity/specificity trade-
off) is consistent with studies showing human radiologist 
performance in detecting symptomatic lung cancer from CXR 
to have sensitivity of 54-84% and specificity of 90% [50]. Our 
results also confirmed our hypothesis relating to the utility of 
the focal loss function for the NIH data set on an 
accuracy/consistency measure. A summary of the experiment 
is below in table V with the set of test metrics shown in table 
VI. 















A BCE TRUE 88 81 12 
B BCE FALSE 91 81 6 
C FOCAL TRUE 91 85 11 
D FOCAL FALSE 92 81 12/14 













A 81 1.0000 0.286 0.792 71 88 
B 81 0.8462 0.750 0.846 25 85 
C 85 1.0000 0.429 0.826 57 91 
D 81 0.9231 0.6259 0.8000 38 86 
 
Before interpreting the candidate decision tree models for 
discussion, we investigated the confusion matrices for the 
highest accuracy results for each experiment to understand the 
predictive value of each model. 
 
A. Model Analysis 
The confusion matrices for the highest accuracy result/s of 
each test shown in figures 7-10 below: 
 
 
Fig. 7. Confusion Matrix for Test A 
 
Fig. 8. Confusion Matrix for Test B. 
 
 
Fig. 9. Confusion Matrix for Test C 
 
Fig. 10. Confusion Matrix and Classification Summary for Test D 
Inspection of the confusion matrices for these best tests in 
figures 7-10 above show that the models tended to 
overclassify as “Malignant” resulting in a very high recall for 
this class at the expense of a high false positives rate for the 
“Benign” test samples. This can be interpreted as resulting 
from the small number of benign samples (36) available in the 
LIDC dataset in comparison to the malignant samples (94). 
Note that in the medical context false positives are preferable 
to false negatives since requisite follow-up radiology such as 
CT scans combined with other clinical indicators will achieve 
more accurate diagnosis [51] and eliminate the false positive. 
On the other hand, a false negative result can lead to a missed 
diagnosis and inaction, which is particularly problematic in 
the case of lung cancer where early detection has been shown 
to significantly improve outcomes [52].  
When we filter these results for lowest false positive rate 
then the results from test B clearly represents the best balance 
between accuracy, sensitivity and specificity with scores of 
81%, 85% and 75% respectively with test D results also 
reasonable.  Tests A and C achieved high accuracy by means 
of sensitivity to the malignant class at the expense of 
specificity for the benign class, resulting in a high false 
positive rate.  These tests (A and C) correspond to the two tests 
utilizing histogram equalization and we suspect that the 
equalization process may reinforced benign features in the 
CXR image which were then mistaken for nodules or masses 
by the classifier, thereby reducing the separability of the 
malignant and benign classes. 
We consider test B to have produced the best results with 
accuracy, sensitivity and specificity consistent with the 
medical literature for human radiological performance [53]  
and showing that this model is good at separating malignant 
samples under the constraints of the small dataset. 
B. Generated Decision Tree Interpretation 
Example decision trees corresponding to these results are 
shown in figures 11 to 14 below. These decision tree models 
explain the scores achieved by each test using a decision path 
and serve to illustrate the result of the end-to-end technique 
presented in this paper. Due to the small sample size of the 
LIDC dataset used for inference, it is not possible to claim that 
these decision tree models are clinically viable. However, 
even on this small dataset the results achieved are reasonable 
and could be expected to be greatly improved with additional 
inferencing samples. For example, the tree model for Test A 
(fig 11) indicates (at the third level of the tree) that a high value 
for “Mass” with a value for “Effusion” between 0 and 28% is 
associated with Malignancy whereas a low value for “Mass” 
along with a high value for “No Finding” is associated with a 
“Benign” classification.  
Recalling that Test B yielded our best results, we expected 
the associated tree model to provide the most meaningful 
insights into the relationship between our selected 
pathological features and lung cancer malignancy.  This 
proved to be the case, with most paths matching our 
understanding of the lung cancer condition.  For example, a 
high value of “Atelectasis” coupled with a high value for 
“Mass” yields a malignant diagnosis.  A low value for 
“Atelectasis” along with a high value for “Effusion” also leads 
to a malignant diagnosis.  Low scores for “Atelectasis” and 
“Effusion” lead to a benign diagnosis as well as low a low 
score for “Mass” along with a high score for “Effusion”, 
which we interpret as non-cancer related effusion caused by 
conditions such as Pneumonia. 
The decision tree generated for Test C associates a high 
score for “Nodule” with Malignancy but is otherwise counter-
intuitive with respect to the “No Finding” and “Mass” classes. 
One interpretation of this may be that the histogram 
equalization process applied to this test may have reduced the 
separability of the “Mass” and “No Finding” features by 
boosting non-malignant features of the “No Finding” class. 
Finally, the decision tree generated for Test D associates a 
high score for “No Finding” with a benign diagnosis unless a 
high score for “Effusion” and a low score for “Atelectasis” are 
present.  Conversely a low score for “No Finding” along with 
a high score for “Atelectasis” is associated with malignancy 
unless the “Atelectasis” score is moderate (between 0.2 and 
0.24) indicating a benign condition. 
Interestingly, both tests B and D associated “Effusion” 
with malignancy which could indicate that these models were 
sensitive enough to automatically detect the build-up of fluid 
and cancer cells between the chest wall and lung associated 
with malignant lung cancer known as Malignant Pleural 
Effusion [54]. 
In general, we found the higher levels of the generated 
decision trees to correspond to our understanding of the lung 
cancer condition, with the lower levels of the tree being less 
consistent and sometimes counter intuitive. We interpret this 
as a result of our small inferencing dataset not providing 
enough samples for the lower levels of the tree to reliably fit. 
 
 
Fig. 11. Automatically Generated Decision Tree for Test A 
 
Fig. 12. Automatically Generated Decision Tree for Test B 
 
Fig. 13. Automatically Generated Decision Tree for Test C 
 
Fig. 14. Automatically Generated Decision Tree for Test D 
VII. DISCUSSION AND FUTURE DIRECTIONS 
We have described a method whereby interpretable 
decision trees fitted to multiple features extracted from CXR 
images (using deep learning) have been used to separate an 
independent lung nodule dataset into benign or malignant 
classes with good results. 
The described results show the potential of hybrid 
computer vision techniques in automatically generating 
diagnostic scoring models from CXR image data.  
Interestingly, the model from Test A shows apparent 
relationship between malignant lung cancer originating from 
the lung and the presence of Effusion and Mass on the LIDC 
CXR images, with Mass scores over 3% and Effusion scores 
between 4 and 28% resulting in a Malignant classification of 
22.1% of the samples.  Similarly, in Model A the No Finding 
class correctly leads to a Benign classification for a score 
greater than 2%.  This could indicate that Model A was 
sensitive enough to automatically detect the build-up of fluid 
and cancer cells between the chest wall and lung associated 
with malignant lung cancer known as Malignant Pleural 
Effusion [54].  Whilst none of the generated models could be 
considered to be fit for clinical purposes at this stage, the fact 
that a number of models were generated that contain 
reasonable insights suggests that the techniques used here are 
able to capture important pathological information and are 
worthy of further refinement. 
Using a novel combination of machine deep learning and 
decision tree analysis, we have automatically generated lung 
cancer diagnostic models that are capable of stratifying lung 
cancer patients into benign/malignant categories with best 
accuracy approaching 85% and best PPV of 83% for the 
malignant class.  False positives tend to be high for all models 
driven by relatively poor sensitivity to the benign 
classification with best recall for this class being only 43%.  
Given the limitations of the datasets used, and in particular the 
small size of the LIDC dataset used for diagnostic ground 
truth, these results suggest that with additional data and further 
refinement this method could potentially be used to develop 
useful clinical methods to assist in the diagnosis and scoring 
of lung cancer.  Examples of such future refinements include: 
- Sourcing of additional datasets for deep-learning 
training and decision tree fitting;   
- Employ techniques to improve signal-to-noise ratio to 
improve deep learning accuracy and generalization; 
- Testing with targeted clinical validation; 
- Implementation in a federated learning framework to 
assure data security and provide a scalable pathway to 
the acquisition of a broad-base dataset supporting 
continuous model improvement. 
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